United States spent $162 million on remdesivir development but holds no patents, review finds,

A new government report says the United States spent $162 million getting Gilead … The drug fizzled against Ebola in a clinical trial in Africa but showed promise against coronaviruses. The largest …, A new government report says the United States spent $162 million getting Gilead … The drug fizzled against Ebola in a clinical trial in Africa but showed promise against coronaviruses. The largest …, Read More

Scroll to Top